期刊文献+

结肠癌DLD-1细胞肿瘤干细胞富集模型的比较 被引量:3

Comparison of enrichment model of cancer stem cells in colon cancer DLD-1 cells
原文传递
导出
摘要 目的 比较3种富集结肠癌DLD-1细胞肿瘤干细胞的培养模型的效果.方法 用含不同浓度生长因子的无血清培养基分为3组悬浮培养DLD-1细胞获得细胞球,其中G1组方案:10 ng/mL上皮生长因子(EGF)+10 ng/mL成纤维细胞生长因子(bFGF);G2组方案:20 ng/mL EGF+ 10 ng/mL bFGF;G3组方案:20 ng/mL EGF +20 ng/mL bFGF.流式细胞术检测细胞球中CD133+ CD44+、CD133+、CD44+、ALDH+细胞比例变化;Real-time PCR检测细胞球中干细胞基因(Oct4、Sox2、Nanog)及CSCs基因(CD133、CD44、CD166、ALDH、CD66c) mRNA表达变化;成球实验检测细胞球自我更新能力变化;平板克隆形成实验检测细胞体外成瘤能力变化.正态分布的计量资料以x-±s表示,多组间比较采用单因素方差分析,两两比较采用配对样本t检验.结果 流式细胞术检测结果:G1组、G2组和G3组细胞中CD133+ CD44+细胞比例分别为0.030±0.010、0.113±0.012、0.043±0.006,3组比较,差异有统计学意义(F=67.625,P<0.05);G2组中CD133+ CD44+细胞比例分别与G1组和G3组比较,差异均有统计学意义(=9.449,12.124,P<0.05);G1组与G3组比较,差异无统计学意义(t=-4.000,P>0.05).G1组、G2组和G3组细胞中CD133+细胞比例分别为0.037±0.015、0.027 ±0.006、0.023 ±0.006,3组比较,差异无统计学意义(F=1.444,P>0.05).G1组、G2组和G3组细胞中CD44+细胞比例分别为20.103±4.761、44.600±2.138、44.387±2.117,3组比较,差异有统计学意义(F=56.269,P<0.05);G1组中CD44+细胞比例分别与G2组和G3组比较,差异均有统计学意义(t=-10.024,-14.696,P<0.05);G2组与G3组比较,差异无统计学意义(t=0.131,P>0.05).G1组、G2组和G3组细胞中ALDH+细胞比例分别为0.060 ±±0.010、0.627±0.068、0.043 ±±0.021,3组比较,差异有统计学意义(F =192.097,P<0.05);G2组中ALDH+细胞比例分别与G1组和G3组比较,差异均有统计学意义(t=12.962,21.380,P<0.05);G1组与G3组比较,差异无统计学意义(t=2.500,P>0.05).Real-time PCR检测结果:G1组、G2组和G3组干细胞基因Oct4、Sox2、Nanog及CSCs基因CD133、CD44、CD166、ALDH、CD66c mRNA表达分别为1.272±0.152、11.636±3.164、1.420 ±0.201,4.717±0.409、8.262±1.079、4.827±0.446,1.836±0.417、12.883±4.030、1.636±0.589,1.555±0.397、4.367±1.109、1.208 ±0.165,25.853 ±4.544、59.483±8.950、26.924±4.134,21.223±1.088、57.847±5.880、21.710±4.010,19.378±2.479、78.211±9.879、18.475±3.571,4.737±2.105、18.003±3.826、5.211±1.474;各组上述基因mRNA表达比较,差异有统计学意义(F=31.529,23.865,21.557,19.102,27.837,76.608,90.530,23.997,P<0.05).上述基因mRNA表达中,G2组分别与G1组和G3组比较,差异均有统计学意义(t=5.950,8.997,5.257,5.507,5.766,9.158,11.507,6.730;5.428,7.782,4.340,5.583,4.979,6.829,7.937,8.445,P<0.05);G1组与G3组比较,差异无统计学意义(t=-0.797,-0.555,0.392,2.539,-1.004,-0.232,0.265,-0.675,P>0.05).成球实验检测结果:G1组、G2组和G3组细胞球数分别为(182±34)个、(396±22)个、(217 ±22)个,3组比较,差异有统计学意义(F =56.128,P<0.05).G2组中细胞球数分别与G1组和G3组比较,差异均有统计学意义(t=6.698,9.483,P<0.05);G1组与G3组比较,差异无统计学意义(t=-1.904,P>0.05).平板克隆形成实验检测结果:G1组、G2组和G3组细胞体外形成克隆数分别为(230±33)个、(403±32)个、(266±36)个,3组比较,差异有统计学意义(F =22.111,P<0.05).G2组中细胞体外形成克隆数分别与G1组和G3组比较,差异均有统计学意义(t=5.053,4.913,P<0.05);G1组与G3组比较,差异无统计学意义(t=-2.073,P>0.05).结论 20 ng/mL EGF+ 10 ng/mL bFGF方案更能有效富集结肠癌DLD-1细胞的肿瘤干细胞. Objective To compare the effects of 3 enrichment models of cancer stem cells (CSCs) in colon cancer DLD-1 cells.Methods DLD-1 cells were cultured in 3 kinds of serum-free medium containing various growth factors to generate spheroid cells,including G1 group using 10 ng/mL EGF + 10 ng/mL bFGF,G2 group using 20 ng/mL EGF + 10 ng/mL bFGF and G3 group using 20 ng/mL EGF + 20 ng/mL bFGF.The cell proportion of CD133 + CD44 +,CD133 +,CD44 + and ALDH + were confirmed by flow cytometery.The mRNA expression of stem cells related genes (Oct4,Sox2,Nanog) and colon CSCs genes (CD133,CD44,CD166,ALDH,CD66c) were detected by real-time polymerase chain reaction (RT-PCR).The capacity of self-renewal was detected by sphere-forming assay.The tumorigenesis in vivo was measured by colony formation assay.Measurement data with normal distribution were presented as x-± s,comparisons among groups were analyzed using the one-way ANOVA,and pairwise comparisons were done by the paired-samples t test.Results The results of flow cytometery:the proportion of CD133 + CD44 + cells in the G1,G2 and G3 groups were 0.030 ± 0.010,0.113 ± 0.012 and 0.043 ± 0.006,respectively,with a significant difference among the 3 groups (F =67.625,P < 0.05).The proportion of CD133 + CD44+ cells in the G2 group was significantly different from those in the G1 and G3 groups (t =9.449,12.124,P < 0.05),with no significant difference between G1 and G3 groups (t =-4.000,P >0.05).The proportion of CD133 + cells in the G1,G2 and G3 groups were respectively 0.037 ± 0.015,0.027 ±0.006 and 0.023 ± 0.006,with no significant difference among the 3 groups (F =1.444,P >0.05).The proportions of CD44+ cells in the G1,G2 and G3 groups were 20.103 ±4.761,44.600 ±2.138 and 44.387 ± 2.117,respectively,with a significant difference among the 3 groups (F =56.269,P < 0.05).There were significant differences in the proportions of CD44 + cells between G1 group and G2 or G3 group (t =-10.024,-14.696,P < 0.05),and no significant difference between G2 and G3 groups (t =0.131,P > 0.05).The proportion of ALDH + cells in the G1,G2 and G3 groups were 0.060 ±0.010,0.627 ±0.068 and 0.043 ±0.021,respectively,with a significant difference among the 3 groups (F =192.097,P < 0.05).The proportion of ALDH + cells in the G2 group was significantly different from those in the G1 and G3 groups (t =12.962,21.380,P < 0.05),with no significant difference between G1 and G3 groups (t =2.500,P > 0.05).The results of RT-PCR:mRNA expressions of G1,G2 and G3 groups were respectively 1.272 ±0.152,1 1.636 ±3.164 and 1.420 ± 0.201 in stem cell related genes Oct4,4.717 ±0.409,8.262 ± 1.079 and 4.827 ± 0.446 in stem cell related genes Sox2,1.836 ± 0.417,12.883 ± 4.030 and 1.636 ± 0.589 in stem cell related genes Nanog,1.555 ± 0.397,4.367 ± 1.109 and 1.208 ± 0.165 in colon CSCs genes CD133,25.853 ± 4.544,59.483 ±8.950 and 26.924 ±4.134 in colon CSCs genes CD44,21.223 ± 1.088,57.847 ±5.880 and 21.710 ±4.010 in colon CSCs genes CD166,19.378 ±2.479,78.211 ±9.879 and 18.475 ± 3.571 in colon CSCs genes ALDH,4.737 ± 2.105,18.003 ± 3.826 and 5.211 ± 1.474 in colon CSCs genes CD66c,showing significant differences among the 3 groups (F =31.529,23.865,21.557,19.102,27.837,76.608,90.530,23.997,P <0.05).There were significant differences in the mRNA expression of genes between G2 group and G1 or G3 group (t =5.950,8.997,5.257,5.507,5.766,9.158,11.507,6.730;5.428,7.782,4.340,5.583,4.979,6.829,7.937,8.445,P < 0.05),and no significant difference between G1 and G3 groups (t =-0.797,-0.555,0.392,2.539,-1.004,-0.232,0.265,-0.675,P > 0.05).The results of sphereforming assay:the numbers of spheres in the G1,G2 and G3 groups were 182 ± 34,396 ± 22 and 217 ± 22,respectively,showing a significant difference among the 3 groups (F =56.128,P < 0.05).The number of spheres in the G2 group was significantly different from those in the G1 and G3 groups (t =6.698,9.483,P <0.05),with no significant difference between G1 and G3 groups (t =-1.904,P > 0.05).The results of colony formation assay:the numbers of colonies in the G1,G2 and G3 groups were 230 ±33,403 ±32 and 266 ±36,showing a significant difference (F =22.111,P < 0.05).The number of colonies in the G2 group was significantly different from those in the G1 and G3 groups (t =5.053,4.913,P < 0.05),with no significant difference between G1 and G3 groups (t =-2.073,P > 0.05).Conclusion The culturing cells using 20 ng/mL EGF + 10 ng/mL bFGF could effectively promote the enrichment of CSCs in colon cancer DLD-1 cells.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第2期168-172,共5页 Chinese Journal of Digestive Surgery
基金 国家自然科学基金(81402444)
关键词 结肠肿瘤 肿瘤干细胞 富集 悬浮培养 Colonic neoplasms Neoplastic stem cells Enrichment Suspension culture
  • 相关文献

参考文献23

  • 1Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.DOI:10.3322/caac.21208.
  • 2高宇红,薛毅珑,潘静坤.构建hTNF-α/293基因细胞对人结肠癌细胞增殖影响的实验研究[J].局解手术学杂志,2013,22(6):591-593. 被引量:1
  • 3Guo W.Concise review:breast cancer stem cells.:regulatory networks,stem cell niches,and disease relevance[J].Stem Cells Transl Med,2014,3 (8):942-948.DOI:10.5966/sctm.2014-0020.
  • 4Li S,Li Q.Cancer stem cells and tumor metastasis (Review)[J].Int J Oncol,2014,44(6):1806-1812.DOI:10.3892/ijo.2014.2362.
  • 5Leng Z,Tao K,Xia Q,et al.Kruppel-like factor 4 acts as an oneogene in colon cancer stem cell-enriched spheroid cells[J].PLoS One,2013,8(2):e56082.DOI:10.1371/joumah pone.0056082.
  • 6Xie ZY,Lv K,Xiong Y,et al.ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer[J].Oncol Res Treat,2014,37 (11):666-668,670-672.DOI:10.1159/000368842.
  • 7Shimozato O,Waraya M,Nakashima K,et al.Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation[J].Oncogene,2015,94(15):1949-1960.DOI:10.1038/one.2014.141.
  • 8Fitzgerald TL,Rangan S,Dobbs L,et al.The impact of Aldehyde dehydmgenase 1 expression on prognosis for metastatic colon cancer[J].J Surg Res,2014,192(1):82-89.DOI:10.1016/j.jss.2014.05.054.
  • 9Ishizawa K,Rasheed ZA,Karisch R,et al.Tumor-initiating cells are rare in many human tumors[J].Cell Stem Cell,2010,7(3):279-282.DOI:10.1016/j.stem.2010.08.009.
  • 10Rybak AP,He L,Kapoor A,et al.Characterization of spherepropagating cells with stem-like properties from DU145 prostate cancer cells[J].Biochim Biophys Acta,2011,1813 (5):683-694.DOI:10.1016/j.bbamcr.2011.01.018.

二级参考文献13

  • 1Jemal A, Bray F, Center MM, et al. Global cance rstatistics [ J ]. CA Cancer J Clin ,2011,61 (2) :69 - 90.
  • 2Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five con- tinents : a worldwide population-based study ( CONCORD ) [ J ]. Lancet Onco1,2008,9 ( 8 ) :730 - 756.
  • 3Chen Q, Liu ZC, Cheng LP,et al. An analysis of incidence and mortality of color ectal cancer in China, 2003-2007 [ J]. China Cancer, 2012,21 (3) :179 - 182.
  • 4Houghton AN. LIGHTing the way for tumor immunity[ J ]. Nat Immunol, 2004,5 (2) : 123 - 124.
  • 5Thomas, Kilibanov AM. Non-viral gene therapy: polycation-mediated DNA delivery [ J ]. Appl Microbiol Biotechno1,2003,62 ( 1 ) :27 - 34.
  • 6Asensio AC, Rodrfguez-Ferrer CR, Oaknin S, et al. Biochemical and im- inunochemica.l characterisation of human diadenosine triphosphatase provides evidence for its identification with the turnout suppressor Fhit protein[ J]. Biochimie ,2006,88 ( 5 ) :461 - 471.
  • 7Ass/imaki R, Sarlomo-Rikala M, Lopez-Guerrero JA, et al. Array compar- ative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors[ J]. Genes Chromo- somes Cancer,2007,46 ( 6 ) :564 - 576.
  • 8Campochiaro PA. Gene therapy for ocular neovascularization [ J ]. Curr Gene Ther,2007,7( 1 ) :25 -33.
  • 9Xu Z, Vu T, Lee /-I, et al. Population phannacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody,in pa- tients with psoriatic arthritis [ J ] J Clin Pharmacol,2009,49 (9) : 1056 - 1070.
  • 10Vandenbroucke K,de Haard H,Beirnaert E, et al. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chro- nic colitis[ J]. Mucosal hnmuno1,2010,3 ( 1 ) :49 - 56.

同被引文献27

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部